Novo Nordisk faces a sharp decline in sales of its injectable diabetes drugs, including Ozempic, due to intense competition ...

Copenhagen: Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second quarter net profit Wednesday, but rising ...

Novo Nordisk is facing a sharp decline in sales of its injectable diabetes drugs, including Ozempic, due to increased competition and potential US tariffs.

Experts reveal potential unintended Ozempic side effect – and whether we should worry - Researchers found Ozempic-induced ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.